Ra Pharmaceuticals, Inc. (NASDAQ: RARX) today announced the pricing of an underwritten public offering of 8,387,097 shares of its common ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Equity Offerings

Ra Pharmaceuticals Announces Pricing of Public Offering of Common StockDecember 11, 2018 6:32 PM Pre-Open Movers 12/11: (YMAB) (ENTX) (GPS) Higher; (OPK) (SFIX) (CAMP) Lower (more...)December 11, 2018 9:29 AM After-Hours Movers 12/10: (ASNA) Higher; (SEAC) (SFIX) (CAMP) Lower (more...)December 10, 2018 5:27 PM Ra Pharmaceuticals (RARX) Announces Proposed $100M Public Offering of Common StockDecember 10, 2018 4:01 PM Alexion Pharma (ALXN) Could Consider Buying Ra Pharmaceuticals (RARX) Outright - RBCDecember 10, 2018 1:46 PM Ra Pharma (RARX) PT Raised to $35 at SunTrust Robinson HumphreyDecember 10, 2018 12:35 PM Ra Pharma (RARX) PT Raised to $34 at BMO CapitalDecember 10, 2018 10:21 AM Ra Pharma (RARX) PT Raised to $40 at JefferiesDecember 10, 2018 10:14 AM Ra Pharmaceuticals (RARX) Reports Positive Top-line Data from Phase 2 Trial of Zilucoplan in Patients with Generalized Myasthenia GravisDecember 10, 2018 7:01 AM